Shanghai, China—November 11, 2022—
2022 BioCentury-BayHelix East-West Summit, co-hosted by Biocentury, BayHelix and McKinsey & Company, will take place from 14-18 November 2022. The summit will be run as combination of offline live and online virtual. More than 700 C-suite professionals from pharmaceutical, industrial and financial fields will come together in San Francisco from 14-16 November 2022 for an offline conference, and 17-18 November for a two-day online 1×1 meetings.
The summit aims to set up a communication platform between domestic and foreign innovators, investors and entrepreneurs in biotech and life-science fields to discuss who will drive the development of China’s Biopharmaceutical innovation ecosystem and what business strategies companies should adopt to transform domestic and multinational BioPharma and medical technologies.
As biotechs pursue out-licensing to create value and reach patients in both the East and West, C-Suite leaders must generate a portfolio of assets with globally competitive data. Dr. Ning Xia, Founder&CEO of Chemical.AI was invited to attend the Summit’s 7th R&D Roundtable on the theme “Prioritizing Your Portfolio for Globalization”, “Scientist CEOs”, and Heads of Research and Business Development discuss “how R&D strategy is evolving to meet this higher bar.”
About Chemical.AI
Founded in 2018, Chemical.AI is one of the technology leading companies leveraging Artificial Intelligence (AI) and big data to transform research and development to shape the future of chemistry. ChemAIRS boosts success rates in synthesis route design and prediction with diverse synthesis strategies. In 2021, Chemical.AI also established an AIoT automation lab (ChemAILab) in Shanghai to bring dry lab and wet lab together to provide more professional and efficient chemical synthesis services to the industry.
For more information, please go to website https://www.chemical.ai/ and register with a promotion code CF41MT to redeem your two-week free trial.
Contact bd@chemical.ai for immediate inquiries.
